Literature DB >> 17761614

Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study.

R Graham Barr1, Sonia Mesia-Vela, John H M Austin, Robert C Basner, Brad M Keller, Anthony P Reeves, Daichi Shimbo, Lori Stevenson.   

Abstract

RATIONALE: Basic science research suggests a causal role for endothelial dysfunction in chronic obstructive pulmonary disease (COPD). Clinical studies examining endothelial function are lacking, particularly early in the disease. Flow-mediated dilation (FMD) is a physiologic measure of endothelial reactivity to endogenous nitric oxide.
OBJECTIVES: We hypothesized that lower FMD among former smokers would be associated with lower post-bronchodilator FEV(1), higher percentage of emphysema using computed tomography (CT) and lower diffusing capacity.
METHODS: We measured FMD, pulmonary function, and CT percentage of emphysema in a random sample of 107 cotinine-confirmed former smokers in the ongoing EMCAP study. FMD was defined as percentage change in the brachial artery diameter with reactive hyperemia. Generalized additive models were used to adjust for potential confounders and assess linearity.
MEASUREMENTS AND MAIN RESULTS: Mean age of participants was 71 +/- 5 years, 46% were female, and pack-years averaged 48 +/- 26. Mean FMD was 3.8 +/- 3.1%; mean post-bronchodilator FEV(1), 2.3 +/- 0.8 L; and mean CT percentage of emphysema, 26 +/- 10%. A 1 SD decrease in FMD was associated with a 132-ml (95% confidence interval, 16-248 ml; P = 0.03) decrement in post-bronchodilator FEV(1) and a 2.6% (95% confidence interval, 0.5-4.7%; P = 0.02) increase in CT percentage of emphysema in fully adjusted models. These associations were linear across the spectrum from normality to disease, independent of smoking history, and also significant among participants without COPD. Associations with diffusing capacity were consistent but nonsignificant (P = 0.09). The FMD-FEV(1) association was entirely attributable to percentage of emphysema.
CONCLUSIONS: Impaired endothelial function, as measured by FMD, was associated with lower FEV(1) and higher CT percentage of emphysema in former smokers early in COPD.

Entities:  

Mesh:

Year:  2007        PMID: 17761614      PMCID: PMC2176103          DOI: 10.1164/rccm.200707-980OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  37 in total

1.  Pulmonary emphysema with special reference to vascular changes.

Authors:  A A LIEBOW
Journal:  Am Rev Respir Dis       Date:  1959-07

2.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

3.  Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke.

Authors:  S Patrick Nana-Sinkam; Jong Deog Lee; Sylk Sotto-Santiago; Robert S Stearman; Robert L Keith; Qamrul Choudhury; Carlyne Cool; Jane Parr; Mark D Moore; Todd M Bull; Norbert F Voelkel; Mark W Geraci
Journal:  Am J Respir Crit Care Med       Date:  2007-01-25       Impact factor: 21.405

4.  Reduced pulmonary function is associated with central arterial stiffness in men.

Authors:  M Zureik; A Benetos; C Neukirch; D Courbon; K Bean; F Thomas; P Ducimetière
Journal:  Am J Respir Crit Care Med       Date:  2001-12-15       Impact factor: 21.405

5.  Standardization of Spirometry, 1994 Update. American Thoracic Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1995-09       Impact factor: 21.405

6.  The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort.

Authors:  Daichi Shimbo; Cairistine Grahame-Clarke; Yumiko Miyake; Carlos Rodriguez; Robert Sciacca; Marco Di Tullio; Bernadette Boden-Albala; Ralph Sacco; Shunichi Homma
Journal:  Atherosclerosis       Date:  2006-06-08       Impact factor: 5.162

7.  Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease.

Authors:  Hiroshi Kanazawa; Kazuhisa Asai; Kazuto Hirata; Junichi Yoshikawa
Journal:  Am J Med       Date:  2003-04-01       Impact factor: 4.965

8.  Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease.

Authors:  Salud Santos; Victor I Peinado; Josep Ramirez; Jaime Morales-Blanhir; Ricardo Bastos; Josep Roca; Robert Rodriguez-Roisin; Joan A Barbera
Journal:  Am J Respir Crit Care Med       Date:  2003-02-20       Impact factor: 21.405

9.  Close relation of endothelial function in the human coronary and peripheral circulations.

Authors:  T J Anderson; A Uehata; M D Gerhard; I T Meredith; S Knab; D Delagrange; E H Lieberman; P Ganz; M A Creager; A C Yeung
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

10.  Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults.

Authors:  D S Celermajer; K E Sorensen; D Georgakopoulos; C Bull; O Thomas; J Robinson; J E Deanfield
Journal:  Circulation       Date:  1993-11       Impact factor: 29.690

View more
  76 in total

1.  Brachial artery diameter and the right ventricle: the Multi-Ethnic Study of Atherosclerosis-right ventricle study.

Authors:  Christopher T Dibble; Daichi Shimbo; R Graham Barr; Emilia Bagiella; Harjit Chahal; Corey E Ventetuolo; David M Herrington; Joao A C Lima; David A Bluemke; Steven M Kawut
Journal:  Chest       Date:  2012-12       Impact factor: 9.410

2.  Heterogeneity of pulmonary perfusion as a mechanistic image-based phenotype in emphysema susceptible smokers.

Authors:  Sara K Alford; Edwin J R van Beek; Geoffrey McLennan; Eric A Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

3.  Passive leg movement in chronic obstructive pulmonary disease: evidence of locomotor muscle vascular dysfunction.

Authors:  Stephen J Ives; Gwenael Layec; Corey R Hart; Joel D Trinity; Jayson R Gifford; Ryan S Garten; Melissa A H Witman; Jacob R Sorensen; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2020-04-23

4.  Vascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance.

Authors:  Stephen J Ives; Ryan A Harris; Melissa A H Witman; Anette S Fjeldstad; Ryan S Garten; John McDaniel; D Walter Wray; Russell S Richardson
Journal:  Hypertension       Date:  2013-12-09       Impact factor: 10.190

5.  Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study.

Authors:  R Graham Barr; Sonia Mesia-Vela; John H M Austin; Robert C Basner; Brad M Keller; Anthony P Reeves; Daichi Shimbo; Lori Stevenson
Journal:  Am J Respir Crit Care Med       Date:  2007-08-29       Impact factor: 21.405

6.  Quantitative and semiquantitative measures of regional pulmonary microvascular perfusion by magnetic resonance imaging and their relationships to global lung perfusion and lung diffusing capacity: the multiethnic study of atherosclerosis chronic obstructive pulmonary disease study.

Authors:  Katja Hueper; Megha A Parikh; Martin R Prince; Christian Schoenfeld; Chia Liu; David A Bluemke; Stephen M Dashnaw; Thomas A Goldstein; Eric A Hoffman; Joao A Lima; Jan Skrok; Jie Zheng; R Graham Barr; Jens Vogel-Claussen
Journal:  Invest Radiol       Date:  2013-04       Impact factor: 6.016

7.  Generative-based airway and vessel morphology quantification on chest CT images.

Authors:  Pietro Nardelli; James C Ross; Raúl San José Estépar
Journal:  Med Image Anal       Date:  2020-03-28       Impact factor: 8.545

Review 8.  Heart-lung interaction via infection.

Authors:  Alison Morris
Journal:  Ann Am Thorac Soc       Date:  2014-01

9.  Percent emphysema and right ventricular structure and function: the Multi-Ethnic Study of Atherosclerosis-Lung and Multi-Ethnic Study of Atherosclerosis-Right Ventricle Studies.

Authors:  Maria Grau; R Graham Barr; Joao A Lima; Eric A Hoffman; David A Bluemke; J Jeffrey Carr; Harjit Chahal; Paul L Enright; Aditya Jain; Martin R Prince; Steven M Kawut
Journal:  Chest       Date:  2013-07       Impact factor: 9.410

10.  Percent emphysema, airflow obstruction, and impaired left ventricular filling.

Authors:  R Graham Barr; David A Bluemke; Firas S Ahmed; J Jeffery Carr; Paul L Enright; Eric A Hoffman; Rui Jiang; Steven M Kawut; Richard A Kronmal; João A C Lima; Eyal Shahar; Lewis J Smith; Karol E Watson
Journal:  N Engl J Med       Date:  2010-01-21       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.